CURE Foundation's Research Grants

CURE Foundation's Research Grants is sponsored by CURE Foundation. Invests in cutting-edge treatments, innovative research, and support projects to enhance healthcare outcomes for breast cancer patients in Canada.

Childhood Cancer Research Funding - For Researchers - CURE Press enter to begin your search CURE Childhood Cancer’s mission is to conquer childhood cancer through funding targeted research while supporting patients and their families.

CURE invests millions of dollars each year into the most promising childhood cancer research , working to ensure children have the best chance to survive their cancer without sacrificing their future health and quality of life. CURE offers two different types of childhood cancer research grants: the Translation to Clinic (T2C) award and the Early Investigator (EI) award.

Translation to Clinic award (T2C) – open to investigators at any stage of their career (Assistant to Full Professor). The award term will be up to 2 years with support of $150,000 per year in direct costs plus 10% indirect costs (Total award = $330,000). Early Investigator award (EI) – open to beginning scientists and physician scientists at the Instructor or Assistant Professor level.

Physician scientists (MD or MD/PhD) who are within 5 years of completion of their clinical (or terminal) fellowship training and are beginning to establish a research career may apply as Instructors or Assistant Professors. PhD scientists within 5 years of an initial appointment as a tenure track Assistant Professor are also invited to apply for this award.

The award term will be up to 2 years with support of $100,000 per year in direct costs plus 10% indirect costs (Total award = $220,000).

January 9, 2026 – Application opened for LOI submissions February 13, 2026 – Deadline for LOI submissions March 5, 2026 – Invite selected applications to apply March 30, 2026 – Deadline for applications Applicants are notified of funding decisions prior to June 30, 2026 CURE’s childhood cancer research funding cycles follow our fiscal year: July 1 – June 30.

The LOI is limited to 1 page and should include Rationale, Hypothesis, Aims, Research Design, and Impact/Innovation. Additional attachments required are (1) a list of 10 key references and (2) a PI biosketch. Grant Guidelines, Policies, and Instructions for our FY 2026 funding cycle.

Grant Policies and Instructions Frequently Asked Questions: How do I submit a proposal for childhood cancer research funding? CURE utilizes ProposalCentral to administer our research process. Please follow the link below to apply.

How are research funding decisions made? All proposals are reviewed by our Peer Review Committee and scored for scientific merit and alignment with CURE’s research goals. The PRC makes recommendations to the Board of Directors, which ultimately decides what proposals to fund.

Decisions are based on scores and the amount of funds available. Does CURE award multi-year grants? Yes.

Our Translation to Clinic and Early Investigator awards have an award term of up to 2 years. What is the typical grant size? There really is not a “typical” grant award.

All proposals must include a detailed budget, and that is reviewed and evaluated by the Peer Review Committee. Are indirect costs allowed? Yes.

We allow 10% of the award total in indirect costs. Who can I contact with questions? Please direct questions to [email protected] .

200 Ashford Center North, Suite 250 CURE Childhood Cancer is a non-profit 501(c)(3) organization. IRS identification number 58-1244138. Alex Cawood’s Universe Fund Jesselyn “JessZilla” Silva Fund Sharon Bryan Open Arms Fund Trenton W.

Kindred Research Fund Savannah Leadership Council Young Professional Leadership Council Formulario de Información Familiar Childhood Cancer Awareness Month